Dalton CF - Search Results

1

Phospholipid fatty acids and neurotoxicity in human neuroblastoma SH-SY5Y cells.

Reynolds LM, Dalton CF, Reynolds GP. Reynolds LM, et al. Among authors: dalton cf. Neurosci Lett. 2001 Aug 31;309(3):193-6. doi: 10.1016/s0304-3940(01)02071-7. Neurosci Lett. 2001. PMID: 11514074

2

Transgenic models and subcellular pathology--do they tell us what goes wrong in Huntington's disease?

Reynolds GP, Dalton CF. Reynolds GP, et al. Among authors: dalton cf. Mol Psychiatry. 1998 May;3(3):192-5. doi: 10.1038/sj.mp.4000374. Mol Psychiatry. 1998. PMID: 9672887 No abstract available.

3

Brain neurotransmitter deficits in mice transgenic for the Huntington's disease mutation.

Reynolds GP, Dalton CF, Tillery CL, Mangiarini L, Davies SW, Bates GP. Reynolds GP, et al. Among authors: dalton cf. J Neurochem. 1999 Apr;72(4):1773-6. doi: 10.1046/j.1471-4159.1999.721773.x. J Neurochem. 1999. PMID: 10098889 Free article.

4

Methylenetetrahydrofolate reductase (MTHFR) 677C/T polymorphism is associated with antipsychotic-induced weight gain in first-episode schizophrenia.

Srisawat U, Reynolds GP, Zhang ZJ, Zhang XR, Arranz B, San L, Dalton CF. Srisawat U, et al. Among authors: dalton cf. Int J Neuropsychopharmacol. 2014 Mar;17(3):485-90. doi: 10.1017/S1461145713001375. Epub 2013 Nov 13. Int J Neuropsychopharmacol. 2014. PMID: 24229535 Free article.

5

Methylation at a transcription factor-binding site on the 5-HT1A receptor gene correlates with negative symptom treatment response in first episode schizophrenia.

Tang H, Dalton CF, Srisawat U, Zhang ZJ, Reynolds GP. Tang H, et al. Among authors: dalton cf. Int J Neuropsychopharmacol. 2014 Apr;17(4):645-9. doi: 10.1017/S1461145713001442. Epub 2013 Dec 16. Int J Neuropsychopharmacol. 2014. PMID: 24331356 Free article.

6

Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms.

Reynolds GP, McGowan OO, Dalton CF. Reynolds GP, et al. Among authors: dalton cf. Br J Clin Pharmacol. 2014 Apr;77(4):654-72. doi: 10.1111/bcp.12312. Br J Clin Pharmacol. 2014. PMID: 24354796 Free PMC article. Review.

7

Subchronic administration of phencyclidine produces hypermethylation in the parvalbumin gene promoter in rat brain.

Fachim HA, Srisawat U, Dalton CF, Harte MK, Marsh S, Neill JC, Reynolds GP. Fachim HA, et al. Among authors: dalton cf. Epigenomics. 2016 Sep;8(9):1179-83. doi: 10.2217/epi-2016-0050. Epub 2016 Aug 16. Epigenomics. 2016. PMID: 27529801

8

Increased DNA methylation in the parvalbumin gene promoter is associated with methamphetamine dependence.

Veerasakul S, Watiktinkorn P, Thanoi S, Dalton CF, Fachim HA, Nudmamud-Thanoi S, Reynolds GP. Veerasakul S, et al. Among authors: dalton cf. Pharmacogenomics. 2017 Sep;18(14):1317-1322. doi: 10.2217/pgs-2016-0188. Epub 2017 Aug 24. Pharmacogenomics. 2017. PMID: 28835159

9

Parvalbumin promoter hypermethylation in postmortem brain in schizophrenia.

Fachim HA, Srisawat U, Dalton CF, Reynolds GP. Fachim HA, et al. Among authors: dalton cf. Epigenomics. 2018 May;10(5):519-524. doi: 10.2217/epi-2017-0159. Epub 2018 Apr 24. Epigenomics. 2018. PMID: 29688033

10

GRIN2B promoter methylation deficits in early-onset schizophrenia and its association with cognitive function.

Fachim HA, Loureiro CM, Corsi-Zuelli F, Shuhama R, Louzada-Junior P, Menezes PR, Dalton CF, Del-Ben CM, Reynolds GP. Fachim HA, et al. Among authors: dalton cf. Epigenomics. 2019 Feb;11(4):401-410. doi: 10.2217/epi-2018-0127. Epub 2019 Feb 20. Epigenomics. 2019. PMID: 30785307

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters